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Aculeacin A is a lipopeptide that inhibits ,B-glucan synthesis in yeasts. A number of Saccharomyces cerevisiae
mutants resistant to this antibiotic were isolated, and four loci (ACRI, ACR2, ACR3, and ACR4) whose
products are involved in the sensitivity to aculeacin A of yeast ceils were defined. Mutants containing mutations
in the four loci were also resistant to echinocandin B, another member of this lipopeptide family of antibiotics.
In contrast, acri, acr3, and acr4 mutants were resistant to papulacandin B (an antibiotic containing a
disaccharide linked to two fatty acid chains that also inhibits P-glucan synthesis), but acr2 mutants were
susceptible'to this antibiotic. This result defines common and specific steps in the entry and action of aculeacin
A and papulacandin B. The analysis of double mutants revealed an epistatic effect of the acr2 mutation on the
other three mutations. Cell walls of the four different mutants did not show significant alterations in
composition with respect to the parental strain, and in vitro glucan synthase activity was also unaffected.
However, cell surface hydrophobicity in three of the mutants was considerably decreased with respect to the
parental strain.
P-Glucan is the main structural component of the yeast
cell wall, to which it confers its characteristic rigidity (1, 10).
A number of antibiotics are inhibitors of P-glucan synthesis
in yeast species (8). In their presence, the cell wall structure
becomes destabilized and cell lysis occurs unless the me-
dium is protected osmotically. Papulacandin B is an am-
phiphilic molecule with a hydrophilic moiety consisting of
glucose and galactose and a hydrophobic moiety containing
two long-chain unsaturated fatty acids (2). It has been shown
that papulacandin B specifically reduces the levels of p-glu-
can in the cell walls of a number of yeasts (2, 8, 36). On the
other hand, synthesis of a-glucan (which is a major compo-
nent of Schizosaccharomyces pombe cell walls [51) is not
inhibited by papulacandin B (36). Another family of p-glucan
inhibitors comprises aculeacin A, echinocandin B, and cil-
ofungin (LY121019), among others; they contain a cyclopep-
tide moiety linked to a fatty acid chain. Several studies have
demonstrated that in the presence of one of these lipopeptide
antibiotics, synthesis of p-glucan is affected in vivo in yeast
species such as Saccharomyces cerevisiae, Candida albi-
cans, and S. pombe (12, 20, 21, 28, 33, 37, 38). Indirectly,
incorporation of mannoproteins into the walls of yeast cells
treated with aculeacin A or papulacandin B is also inhibited
(22, 35).
The exact mechanism of action of these antibiotics is not
well understood. In vitro, high concentrations of papulacan-
din B inhibit j3-1,3-glucan synthase activity in extracts from
S. pombe or Geotrichum candidum (25, 36), but this antibi-
otic has been observed to be ineffective on extracts from S.
cerevisiae (8, 11). Echinocandin B (28) and cilofungin (33,
34) are noncompetitive inhibitors of the glucan synthase
activity of C. albicans, although in our laboratory neither
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aculeacin A nor echinocandin B inhibits S. cerevisiae P-1,3-
glucan synthase activity (11) when a conventional in vitro
assay for this enzyme (29, 32) is employed. In S. cerevisiae
and C. albicans, glucan synthase is found at the plasma
membrane (24, 29, 32). It is reasonable that in vivo inhibition
of P-glucan synthesis might be a consequence of the direct
interaction of the antibiotic with the synthase; alternatively,
it may be due to some indirect effect. The lipid moiety of the
lipopeptide antibiotics plays an important role in their mech-
anism of action, probably by establishing specific interac-
tions with the membrane (34), and its role in the transport of
the antibiotic through the cell wall and/or plasma membrane
should also be considered. In this context, it can be noted
that although cilofungin differs from aculeacin A and echino-
candin B exclusively in the fatty acid moiety (6), cultures of
two independent S. cerevisiae wild-type strains were resis-
tant to cilofungin at 100 ,ug/ml but not to aculeacin A or
echinocandin B (11).
Ribas et al. (26) have obtained a number of S. pombe
mutants resistant to papulacandin B; some of these mutants
exhibit gross morphological changes and have alterations in
the polysaccharide content of the cell wall. In order to better
understand the mechanism of action of the lipopeptide
antibiotics, we have obtained a collection of S. cerevisiae
mutants resistant to aculeacin A and have begun to charac-
terize some of them. Although this yeast species differs from
others in some aspects of susceptibility to the antibiotics
discussed in this article, it has been chosen because a
simultaneous biochemical and genetic approach can be eas-
ily used with it.
MATERIALS AND METHODS
Yeast strains. S. cerevisiae OLl (MATa leu2-3 leu2-112
his3-11 his3-15 ura3-251 ura3-337) (3) was used as the
parental strain to isolate aculeacin A-resistant mutants.
Strain SEY2101 (MATa ura3-52 leu2-3 leu2-112 suc2-A9
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ade2-1) (9) was used to introduce the ade2 marker into the
OLl background by conventional mating experiments.
Growth media. YPD medium (1% yeast extract, 2% pep-
tone, 2% [wt/vol] glucose) was used as a rich medium. For
some experiments, this was supplemented with 1 M sorbitol
(YPDS medium). In some genetic experiments, YNB me-
dium without amino acids (Difco) plus 2% (wt/vol) glucose
was used as a minimal medium; nutritional requirements
were added as indicated in reference 30. Media were solid-
ified with 1.5% (wt/vol) agar. Cultures were incubated at
30°C unless otherwise indicated. In experiments involving
fractionation of cell wall polysaccharides, cells grown in
YPD medium to the exponential phase were sedimented and
resuspended in fresh YPD medium containing a lower con-
centration of nonradioactive glucose (0.05%, wt/vol) and 0.3
,uCi/ml (0.25 Ci/mmol) of [U-'4C]glucose; incubation was
then continued for 4 h more.
Isolation of aculeacin A-resistant mutants. About 3 x 108
cells from an exponentially growing culture of strain OLl in
YPD medium were mutagenized with ethyl methanesulfo-
nate (30) under conditions where about 40% of the cells
remained viable. Mutagenized cells were washed twice,
resuspended in 10 ml of liquid YPDS medium, and incubated
for 15 h at 24°C. Thirteen aliquots of 50 Rl (106 CFU) each
were plated separately in solid YPD medium containing 1 M
sorbitol plus aculeacin A (15 pug/ml). After 3 days at 24°C,
303 resistant clones were recovered.
Analysis of susceptibility to antibiotics. The antibiotics
were assayed at the concentrations indicated for each exper-
iment by using stock solutions (10 mg/ml in dimethyl sulfox-
ide, kept at -20°C). Two different methods were used for
analyses with liquid media. For parallel tests of a large
number of strains, late-exponential-phase cultures in YPD or
YPDS medium (A600 = 1.0 to 1.5) were diluted 1/100 in test
tubes containing 1 ml of the same medium, the antibiotic
(problem tubes) or an equivalent volume of the solvent
(control tubes) was added 1 h later, and incubation was
continued for 24 h at 30°C. The A6w value reached by each
culture was measured in a Shimadzu UV-240 spectropho-
tometer (1-cm light path). The same procedure was used for
MIC determinations with twofold serial dilutions of the
antibiotic. Alternatively, individual strains were inoculated
into fresh YPD or YPDS medium (with the antibiotic or the
solvent alone) by using 1/50 volume of late-exponential
cultures in the same medium and periodically measuring the
A6. during exponential growth at 30°C. Qualitative analyses
of susceptibility to aculeacin A were also carried out by
streaking the colonies to be tested on solid YPD or YPDS
medium containing the antibiotic at 10 ,ug/ml and incubating
the plates at 30°C for 72 h.
Protoplast obtention and regeneration. Protoplasts were
obtained from exponentially growing cultures as described
previously (35). They were regenerated at 30°C in liquid
YPDS medium containing 0.05% (wt/vol) glucose by initially
resuspending them at a protoplast concentration equivalent
to that of the original cell culture; antibiotics were added (in
some experiments) 1 h after protoplast resuspension, and
[U-'4C]glucose was added 1 h later.
Wall purification and polysaccharide fractionation. Cells
from exponentially growing cultures were broken mechani-
cally by vortexing in the presence of glass beads (0.5- to
0.6-mm diameter) for eight periods of 30 s each, and walls
were purified by repeated washings and differential centrif-
ugation (16). Regenerating protoplasts were broken by re-
suspension in 10 mM Tris chloride buffer (pH 7.5) and
shaking for 10 s with glass beads; the cultures were then
washed repeatedly as described above.
Polysaccharides were fractionated from purified walls
labelled with [U-'4C]glucose as described in reference 22.
Alkali-insoluble material corresponds to ,3-glucan (Zymol-
yase sensitive) plus chitin (Zymolyase resistant), whereas
the alkali-soluble material is divided into a Fehling solution-
precipitable fraction (mannan) and a nonprecipitable fraction
(alkali-soluble P-glucan).
Determination of 0-1,3-glucan synthase activity. Isolation
of membrane fractions and determination of enzyme activity
were done as described in reference 32. Aculeacin A,
echinocandin B, or papulacandin B (from stock solutions at
10 mg/ml in methanol) was added in some assays; control
assays were performed with an equivalent volume of the
solvent alone.
Hydrophobicity assays. Cell surface hydrophobicity (CSH)
in S. cerevisiae populations was determined by two meth-
ods. The phase partition test (27) was used with cyclohexane
in the organic phase. The microsphere hydrophobicity assay
was used as described in reference 18. In the latter assay, the
percentage of hydrophobic cells was considered the CSH
value.
Yeast genetic techniques. Crosses between strains, selec-
tion of diploids, dissection of tetrads, and determination of
nutritional requirements were carried out as described in
reference 30.
Analytical determinations. Wall sugar was determined by
the phenol-sulfuric method (7) with D-glucose as the stan-
dard. Protein concentration was measured by the Lowry
method (18a).
Chemicals and reagents. Radioactive chemicals were from
New England Nuclear (Boston, Mass.). UDP-glucose and
a-amylase were purchased from Boehringer GmbH (Mann-
heim, Germany). 2-Mercaptoethanol, EDTA, bovine serum
albumin, GTP, ATP, amino acids, nitrogen bases, and poly-
styrene microspheres were from Sigma Chemical Company
(St. Louis, Mo.). Aculeacin A was a gift from Toyo Jozo Co.
Ltd., Tagata-gun, Shizuoka-ken, Japan. Papulacandin B was
a gift from CIBA-GEIGY, Basel, Switzerland.
RESULTS
Characterization of aculeacin A-resistant mutants. In order
to isolate aculeacin A-resistant mutants from wild-type
strain OL1, conditions that would also allow the recovery of
thermosensitive or lysis mutants or both were used. Of 303
clones isolated, none was dependent on the presence of
sorbitol as an osmotic stabilizer in the medium for growth.
Five clones were thermosensitive (they did not grow at
37°C), although thermosensitivity did not show meiotic
cosegregation with resistance to the antibiotic. Thus, these
five mutants were not studied further. Another 44 resistant
clones were analyzed for wall polysaccharide composition
by a simplified protocol for 2-ml cultures. None of them
exhibited gross differences with respect to the parental OLl
strain. Six of these clones were employed for further analy-
ses. These were crossed once with strain SEY2101 and then
twice more with the parental OLl strain and in all cases with
selection for resistance to aculeacin A. This phenotype
always showed a 2:2 meiotic segregation pattern, a demon-
stration of the monogenic character of the resistance. The
six resulting isolates employed in the next experiments
(named LMF1l1 to LMF106) have the same genotype as
OL1, aside from the resistance to aculeacin A. All six are
stable in the absence of continued selective pressure.
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TABLE 1. Effects of different antibiotics on
S. cerevisiae acr mutants
MIC (,ug/ml) of:
Strain Aculeacin A
Aculeacin A Papulacandin B Echinocandin B in diploidsa
OLl 5 2.5 10 5
LMF1l1 100 50 50 5
LMF102 50 2.5 >100 5
LMF103 >100 2.5 >100 5
LMF104 100 2.5 75 5
LMF105 100 50 >100 5
LMF106 50 50 50 5
a Diploids were obtained by crossing each mutant strain of the appropriate
mating type with the wild-type strain.
Isolates LMF1l1 to LMF106 of the a mating type were
crossed with the parental strain. All of the resulting diploids
were sensitive to aculeacin A (Table 1); thus, the resistance
mutations are recessive.
Aculeacin A had a variable effect on growth rate depend-
ing on the mutant strain and the presence or absence of
sorbitol in the growth medium (Fig. 1). LMF1l1 was the
most affected strain; its growth rates with respect to control
cultures without the antibiotic were about 45% in YPD
medium and 80% in YPDS medium. The growth defect of
strain LMF106 in YPD medium plus aculeacin A was also
significantly reversed by the osmotic stabilizer (Fig. 1).
The six mutant strains did not exhibit gross morphological
alterations with respect to the parental strain. However,
cultures of LMF1O1 and LMF106 in the absence of sorbitol
contained a certain number of lysed cells, which were not
observed in the presence of the stabilizer. Cultures of the
other mutants were free of lysed cells under all growth
conditions.
Several other phenotypic traits of the mutant strains were
studied (Table 1). The MIC of aculeacin A varied among
strains, being at least 10-fold higher than the value of the
parental strain. All six mutants were also resistant to echino-
candin B. However, while mutants LMF1l1, LMF105, and
LMF106 were also resistant to papulacandin B, strains
LMF102, LMF103, and LMF104 were susceptible to this
antibiotic.
Extraceliular stability of the antibiotic molecules. Resis-
tance in the mutants is not caused by extracellular degrada-
tion of the antibiotic, since cell-free supernatant fluids ob-
tained from 6-h cultures of the mutants grown in the
presence of aculeacin A (5 ,ug/ml) were still able to inhibit
growth of the wild-type strain (11).
Determination of the number of genetic loci defined by
mutants LMFlOl to LMF106. We constructed all possible
diploids by mating all possible pairs of mutants; in each of
the mating experiments, one of the mutants was HIS3 ade2
while the other was his3 ADE2. The 15 diploids were then
sporulated. Both random spore analysis experiments (using
the recessive ade2 marker as the indicator of haploid colo-
nies [see reference 30]) and tetrad analysis indicated that the
resistance mutations carried by LMF102, LMF103, and
LMF104 affect the same locus or closely linked loci. In fact,
TIME (HOURS)
FIG. 1. Growth curves of the parental strain, OL1, and aculeacin A-resistant mutants (LMF1l1 to LMF106) in YPD (0 and 0) or YPDS(U and O) medium at 30°C in the absence (0 and *) or presence (O and l) of aculeacin A (10 Fg/ml). In treated cultures, the antibiotic was
added at time zero.
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TABLE 2. Phenotypes of double acr mutants
Relevant Growth with Dependence onStrain Rent papulacandin B osmoticgenotype (10 jig/ml)" stabilizerb
LMF1l1 acri + +
LMF102 acr2 -
LMF105 acr3 +
LMF106 acr4 + +
LMF107 acrl acr2
LMF108 acrl acr3 +
LMF109 acri acr4 + +
LMF110 acr2 acr3
LMF111 acr2 acr4
LMF112 acr3 acr4 +
a Growth was considered to be inhibited when the A6. reached in the
presence of the antibiotic after 24 h was less than 10%o of that in control tubes.
b Dependence means that the growth rate of the cultures in the presence of
1 M sorbitol was at least twice that observed in the absence of the stabilizer.
no haploid-sensitive spores could be derived from crosses
between these mutants. On the other hand, random spore
analysis resulted in a segregation pattern close to 3:1 for the
aculeacin A resistance: susceptibility character in crosses
among LMF101, LMF105, and LMF106 or between one of
these mutants and one from the group consisting of LMF102,
LMF103, and LMF104, indicating that these mutants carry
independent mutations in separate chromosomes. To con-
firm this, tetrad analyses of the same crosses resulted in
parental ditypes (4:0 segregation pattern for resistance and
susceptibility to aculeacin A), nonparental ditypes (2:2), and
tetratypes (3:1).
Thus, at least four different genes are defined by the six
mutants characterized in this work: ACRI (defined by
LMF101), ACR2 (defined by LMF102), ACR3 (defined by
LMF105), and ACR4 (defined by LMF106).
Epistatic effects among acr mutations. Double acr mutants
were recovered from the aculeacin A-resistant spores
present in nonparental ditype tetrads obtained by crossing
single acr mutants. Two differential phenotypic traits (sus-
ceptibility to papulacandin B and effect of sorbitol on growth
rate) of the double mutants were analyzed (Table 2). The
mutation in acr2 is epistatic to mutations in the other loci,
and the acr3 mutation is also epistatic to acri and acr4.
Cell wall composition in aculeacin A-resistant mutants. The
amount of cell wall sugar was not severely affected in the
strains carrying the four acr mutations in comparison with
the wild type (Table 3). However, the in vivo incorporation
of radioactivity into the walls of mutant cells was not
affected by the antibiotic, while the level of inhibition was
96% in the wild type. As expected, incorporation into the
alkali- and acid-insoluble fra4tion (P-glucan) was most af-
fected in the wild-type strain. Fractionation of wall polysac-
charides from the mutants yielded a pahtern not significantly
different from that of the wild type, ind the presence of
aculeacin A in the mutant cultures did not have an important
effect on the relative percentages (Table 3).
In vitro P-1,3-glucan synthase activity in the acr mutants
as well as in the parental strain was measured (Table 4). All
of the strains had similar levels of GTP- or ATP-activable
glucan synthase activity. Both in the parental and in the
mutant strains, aculeacin A and papulacandin B (at concen-
trations up to 20 ,ug/ml in the assay mixture) and echono-
candin B (up to 40 jxg/ml) did not have an inhibitory effect in
vitro (11).
Effect of aculeacin A and papulacandin B on regenerating
protoplasts. Incorporation of radioactivity into cell wall
polysaccharides in regenerating protoplasts of the parental
and acr strains was sensitive to acule,acin A and papulacan-
din B (30 to 60% of the level of incorporation in the control).
The different polysaccharide fractions were affected to sim-
ilar extents by the antibiotics (11), in accordance with
previous observations with wild-type yeasts (22, 35).
CSH in mutant cells. CSH values for the parental and
mutant strains were determined by the phase partition test
(28) and the microsphere hydrophobicity assay (14). Strains
with the acri, acr3, or acr4 mutation had CSH values of less
than half of the parental value (Table 5). In contrast, the
parental strain and the acr2 mutant had similar CSH values
when CSH was measured by the phase partition test; when
CSH was determined by the microsphere hydrophobicity
assay, acr2 cells displayed a CSH value intermediate be-
TABLE 3. Polysaccharide fractionation of isolated cell walls from ['4C]glucose-labelled cultures
of wild-type and aculeacin A-resistant strainsa
% of wall radioactivity in:
Presence of Amt of wall Alkali-soluble material Alkali-insoluble materialStrain (relevant aculeacin A sugar/cell Wall
genotype) (10 g/ml) (dry wt) radioactivity' Fehling Fehling(10~L/ml) (qg/Mg)b solution solution Acid Acid
precipitable nonprecipitable soluble insoluble
OLl - 44 1 23 48 2 27
+ ND 0.02d
LMF1O1 (acrl) - 46 1 29 37 3 31
+ ND 0.16 28 43 2 27
LMF102 (acr2) - 56 1 26 36 5 33
+ ND 0.37 25 53 3 19
LMF105 (acr3) - 52 1 32 41 1 26
+ ND 0.85 28 52 5 15
LMF106 (acr4) - 39 1 23 45 2 30
+ ND 0.10 21 52 2 25
a Exponentially growing cultures in YPD medium at 250 pg (dry weight) of cells per ml were labelled with ['4C]glucose for 4 h as described in Materials and
Methods. In the aculeacin A-treated cultures, the antibiotic was added 1 h before the isotope.
b Values are the means of results from three independent experiments. ND, not determined.
c Radioactivity values (per milliliter of culture) are normalized with respect to those of untreated cultures, which are given the unit value.
d Walls were not fractionated because of the small amount of radioactivity incorporated.
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TABLE 4. P-Glucan synthase activity in acr mutants
Strain (relevant Nucleotide Sp act (nmol of
genotype) (concn) ~~~~glucose incorporated/genotype) min/mg of protein)
OLl None 6.3
GTP (0.1 mM) 20.8
ATP (4 mM) 19.0
LMF1O1 (acri) None 9.4
GTP (0.1 mM) 16.3
ATP (4 mM) 15.7
LMF102 (acr2) None 8.9
GTP (0.1 mM) 21.7
ATP (4 mM) 20.3
LMF105 (acr3) None 7.8
GTP (0.1 mM) 15.6
ATP (4 mM) 15.9
LMF106 (ac4) None 6.4
GTP (0.1 mM) 16.0
ATP (4 mM) 16.9
tween that of the parental strain and those of the other three
mutants.
Resistance to aculeacin A and resstance to papulac n B
are not necesarily correlated. The properties of the four acr
mutants described above indicate that acquisition of resis-
tance to aculeacin A does not imply resistance to papulacan-
din B in parallel. That is, some of the physiological functions
involved in the action of both antibiotics seem to be common
to both drugs, while others are different for each drug. To
confirm this, a collection of mutants resistant to papulacan-
din B (10 ,ug/ml) was obtained by the same protocol used for
aculeacin A. Of 15 independently obtained mutants, 10 were
also resistant to aculeacin A, while the other 5 showed the
same levels of susceptibility to this antibiotic as the parental
OLl strain.
DISCUSSION
A mutant of C. albicans simultaneously resistant to pap-
ulacandin B and echinocandin B had been isolated previ-
ously (2), and another C. albicans strain obtained as resis-
tant to aculeacin A showed cross-resistance to papulacandin
B (19). A collection of S. pombe papulacandin B-resistant
TABLE 5. CSH in wild-type strain and acr mutants
CSH (mean ± SD) determined by:
Strain (relevant Phase Microsphere
genotype) partition hydrophobicity
testa assayb
OLl 34.1 ± 11.4 31.3 ± 0.8
LMF1O1 (acrl) 14.9 + 6.8 15.1 ± 2.9
LMF102 (acr2) 33.5 ± 9.3 22.2 ± 2.1
LMF105 (acr3) 16.7 t 5.0 14.3 ± 3.7
LMF106 (acr4) 15.3 + 4.1 14.3 + 1.5
I Values correspond to the percentage of cell biomass (measured as A60)
remaining in the cyclohexane phase. They are the means of three independent
experiments (each one involving three measurements).
IValues correspond to the percentage of cells having three or more
microspheres attached. They are the means of three independent experi-
ments.
mutants has been obtained (26), and some of them are still
susceptible to aculeacin A. In the present work with S.
cerevisiae mutants, we have shown that resistance to aculea-
cin A does not necessarily correlate with resistance to
papulacandin B, that is, there are common and specific steps
in the mechanisms of entry and action of these antibiotics.
The functions defined by ACR1, ACR3, and ACR4 are
required for cell sensitivity to both families of antibiotics. In
turn, the physiological function defined by ACR2 is neces-
sary for the sensitivity of cells to aculeacin A although not to
papulacandin B. Interestingly, double mutants with muta-
tions in ACR2 and in one of the other three ACR loci are also
sensitive to papulacandin B; since single mutants with mu-
tations in ACR1, ACR3, or ACR4 are resistant to this
antibiotic, the ACR2 function must remain unaltered for the
effect of papulacandin B to be blocked.
None of the four mutants exhibits gross alterations in cell
wall polysaccharide composition. The mutants contain nor-
mal levels of GTP- or ATP-activable 3-1,3-glucan synthase
activity. This argues against the synthase being directly
altered in any of the acr mutants. Obviously, the possibility
of the existence of more than one activity involved in the
synthesis of 3-1,3-glucan in S. cerevisiae, in a manner
similar to chitin synthesis (4, 23, 31), must be comtemplated.
Synthesis of ,B-1,3-glucan probably is a complex process in
which many different cellular functions are involved.
Since protoplasts from the four independent acr mutants
are sensitive to aculeacin A and papulacandin B, the muta-
tions probably affect cell surface structures or functions
involved in the accessibility of the antibiotic molecules to the
plasma membrane. However, we should not completely
discard the alternative possibility that the physiological
functions affected by aculeacin A or papulacandin B in
regenerating protoplasts do not exactly correspond to those
affected in whole cells; in this respect, the inhibitory effect of
aculeacin A was much less pronounced on protoplasts than
on whole cells in the parental strain. Having considered this,
we still favor the suggestion that the acr mutations alter
entry of the antibiotic molecules into whole cells.
The fact that the three mutants resistant to both aculeacin
A and papulacandin B exhibit lower CSH values than the
wild-type strain points to the importance of surface charge in
the accessibility of the target to the antibiotic molecules.
Several observations suggest that changes in yeast cell wall
proteins are responsible for the modifications in surface
hydrophilicity and hydrophobicity (15, 18). Thus, antibiotic
resistance in the mutants described above may derive more
from fine changes in the wall mannoprotein pattern that alter
CSH than from the overall polysaccharide composition.
CSH may participate, together with other mechanisms, in
the adherence of C. albicans to surfaces in vivo, contributing
to the virulence of this yeast species (13, 17). Therefore,
isolation of aculeacin A- and papulacandin B-resistant mu-
tants can be a strategy for obtaining C. albicans strains with
decreased virulence and for studying the basis of pathoge-
nicity in this yeast species.
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